Study aims to involve parents in early intervention services for children with autism

Early diagnosis and intervention for a child with autism spectrum disorder (ASD) can help change the trajectory of their life. While children can be diagnosed with autism as early as 18-24 months of age, most children are diagnosed between 4-5 years old. Among low income, minority and rural families, the gap is even wider- as a diagnosis typically happens up to one and a half years later than the average. This means that many families are missing the window for early intervention, educational and behavioral services that have been shown to vastly improve outcomes for these children as well as reduce health care costs both in the short and long-term.

Researchers from Boston Medical Center (BMC), in conjunction with researchers from Florida State University and others across the country, are collaborating on a study that aims to get parents involved with early intervention services sooner. The study is funded as part of a five-year $10.2 million grant from the National Institutes of Health, who awarded nearly $100 million to Autism Centers of Excellence across the country.

The research team will test a two-part intervention to engage parents with problem-solving educational tools that will help them better adapt to caring for their child's needs and access the necessary support services available to them. Some parents will also receive training in early social interaction, which teaches parents to support their child's communication and social skills in everyday activities and routines.

Researchers will then evaluate if families with the added training in early social interaction are seeing more growth in social communication skills, development, and other ASD symptoms. From there, they will use the data to create a hybrid intervention and test how feasible it is to implement in a health system.

Patient navigators, who live in the communities where participants reside, will receive training to implement the intervention. Training patient navigators to deliver an evidence- based treatment for ASD has never been done before. If successful, this approach has the potential to address the shortage of linguistically diverse ASD service providers and provide culturally tailored services to traditionally underserved families. Testing the feasibility of the intervention will allow researchers to determine if it could be scaled up and implemented at other locations.

"We know we can diagnose ASD at an early age, and now we need to figure out how to make that happen more frequently and also provide families with the support, education, and treatments they need to ensure their child thrives," said Emily Feinberg, a pediatric researcher at BMC, associate professor of community health sciences at Boston University School of Public Health, and associate professor of pediatrics at BU School of Medicine.

Patients and families will be recruited at BMC and affiliated health centers for the first phase of the study. As an urban, safety-net hospital, BMC's diverse patient population will address the disparities seen in ASD diagnosis and early intervention. Marilyn Augustyn, MD, director of development and behavioral pediatrics at BMC and Lisa Fortuna, MD, medical director for child and adolescent psychiatry at BMC are co-investigators on the study.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Using a molecular testing technology for faster and comprehensive diagnosis of brain tumors